Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence, today announced ...

Scipher will contribute data derived from its PrismRA blood test to the Atropos Evidence Network, which underpins software tools, including an AI chatbot.

Simon Thompson: Self-help measures drive a successful turnaround, but are the shares still worth holding?

Interested in learning more about this Devex member? With a Recruitment Account, you can view the full profile & CV for this member and other professionals around the world. Click here to know more!

WALTHAM, Mass.--(BUSINESS WIRE)--Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Atropos Health, the pioneer in translating real-world clinical data into personalized ...

The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice: www.ft.com/editorialcode ...